CS
TAK icon

Credit Suisse’s Takeda Pharmaceutical TAK Stock Holding History

Credit Suisse’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-12,375
Closed -$193K – 3682
2022
Q4 		$193K Buy
12,375
+55
+0.4% +$768 ﹤0.01% 3192
2022
Q3 		$160K Sell
12,320
-448
-4% -$6.23K ﹤0.01% 3318
2022
Q2 		$179K Hold
12,768
– – ﹤0.01% 3369
2022
Q1 		$183K Sell
12,768
-22,461
-64% -$330K ﹤0.01% 3392
2021
Q4 		$480K Sell
35,229
-24,002
-41% -$337K ﹤0.01% 3842
2021
Q3 		$970K Sell
59,231
-27,566
-32% -$463K ﹤0.01% 3368
2021
Q2 		$1.46M Buy
86,797
+64,951
+297% +$1.11M ﹤0.01% 3096
2021
Q1 		$399K Sell
21,846
-18,521
-46% -$333K ﹤0.01% 3895
2020
Q4 		$735K Sell
40,367
-136,323
-77% -$2.39M ﹤0.01% 3567
2020
Q3 		$3.15M Sell
176,690
-322,074
-65% -$5.86M ﹤0.01% 2099
2020
Q2 		$8.94M Buy
498,764
+423,166
+560% +$7.6M 0.01% 1356
2020
Q1 		$1.15M Sell
75,598
-101,223
-57% -$1.83M ﹤0.01% 2553
2019
Q4 		$3.49M Buy
176,821
+44,748
+34% +$856K ﹤0.01% 2159
2019
Q3 		$2.27M Sell
132,073
-341,690
-72% -$5.91M ﹤0.01% 2379
2019
Q2 		$8.38M Buy
473,763
+273,855
+137% +$4.98M 0.01% 1419
2019
Q1 		$4.07M Sell
199,908
-1,167,972
-85% -$23.5M ﹤0.01% 1880
2018
Q4 		$23M Buy
+1,367,880
New +$23.1M 0.02% 725

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Credit Suisse's TAK Position: Q1 2023 in Review

Credit Suisse sold out of Takeda Pharmaceutical (TAK) in Q1 2023, closing a stake of 12,375 shares — an estimated $193K sold.

Credit Suisse first reported a position in TAK in Q4 2018 and held it in 17 quarters. The position peaked at $23M in Q4 2018. 301 funds tracked by Wall St. Rank hold TAK as of Q1 2023.

  • Credit Suisse reported no remaining Takeda Pharmaceutical position as of Q1 2023 after selling out during the quarter.
  • Credit Suisse sold 12,375 Takeda Pharmaceutical shares in Q1 2023, an estimated $193K.
  • Credit Suisse first reported a position in Takeda Pharmaceutical in Q4 2018 and held it in 17 quarters.
  • Credit Suisse's Takeda Pharmaceutical position peaked at $23M in Q4 2018.
  • 301 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q1 2023.

Based on Credit Suisse's 13F filing for Q1 2023, filed 10 May 2023.